CD70-targeted immunoPET Imaging of Malignant Cancers

NCT06852638 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Renal Cancer
Renal Clear Cell Carcinoma
Lymphoma
Lymphoma, Large B-Cell, Diffuse
Follicular Lymphoma
Mantle Cell Lymphoma
Nasopharyngeal Carcinoma

Interventions

DRUG: [18F]F-RESCA-RCCB6
DRUG: [18F]F-RESCA-R8B4
DRUG: [68Ga]Ga-NOTA-R8B4
DRUG: [18F]F-RESCA-RD06
DRUG: [68Ga]Ga-NOTA-RD06

Sponsor

RenJi Hospital